Current treatment options in patients with mastocytosis: status in 2015 and future perspectives
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Current treatment options in patients with mastocytosis: status in 2015 and future perspectives
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF HAEMATOLOGY
Volume 94, Issue 6, Pages 474-490
Publisher
Wiley
Online
2015-03-10
DOI
10.1111/ejh.12544
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparison of bone marrow versus peripheral blood allogeneic hematopoietic stem cell transplantation for hematological malignancies in adults—a systematic review and meta-analysis
- (2015) Udo Holtick et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Denosumab for the treatment of osteoporosis
- (2015) Sarah Zaheer et al. Expert Opinion on Drug Metabolism & Toxicology
- Update on rupatadine in the management of allergic disorders
- (2014) J. Mullol et al. ALLERGY
- Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposal
- (2014) P. Valent et al. ANNALS OF ONCOLOGY
- A new human mast cell line expressing a functional IgE receptor converts to tumorigenic growth by KIT D816V transfection
- (2014) R. Saleh et al. BLOOD
- Novel thiazole amine class tyrosine kinase inhibitors induce apoptosis in human mast cells expressing D816V KIT mutation
- (2014) Yanli Jin et al. CANCER LETTERS
- Interleukin-31: A Novel Diagnostic Marker of Allergic Diseases
- (2014) Anja Rabenhorst et al. CURRENT ALLERGY AND ASTHMA REPORTS
- CD52 is a molecular target in advanced systemic mastocytosis
- (2014) Gregor Hoermann et al. FASEB JOURNAL
- Molecular Defects in Mastocytosis
- (2014) Siham Bibi et al. IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA
- Bone Involvement and Osteoporosis in Mastocytosis
- (2014) Maurizio Rossini et al. IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA
- Treatment Strategies in Mastocytosis
- (2014) Frank Siebenhaar et al. IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA
- CD30 in Systemic Mastocytosis
- (2014) Bjorn van Anrooij et al. IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA
- Diagnostic Criteria and Classification of Mastocytosis in 2014
- (2014) Cem Akin et al. IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA
- Hematopoietic Stem-Cell Transplantation for Advanced Systemic Mastocytosis
- (2014) Celalettin Ustun et al. JOURNAL OF CLINICAL ONCOLOGY
- The immunophenotype of mast cells and its utility in the diagnostic work-up of systemic mastocytosis
- (2014) Cristina Teodosio et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Ponatinib Induces Apoptosis in Imatinib-Resistant Human Mast Cells by Dephosphorylating Mutant D816V KIT and Silencing -Catenin Signaling
- (2014) B. Jin et al. MOLECULAR CANCER THERAPEUTICS
- Omalizumab as a Desensitizing Agent and Treatment in Mastocytosis: A Review of the Literature and Case Report
- (2014) Kristin C. Sokol et al. Journal of Allergy and Clinical Immunology-In Practice
- Systemic mastocytosis in adults: 2013 update on diagnosis, risk stratification, and management
- (2013) Animesh Pardanani AMERICAN JOURNAL OF HEMATOLOGY
- Comprehensive mutational profiling in advanced systemic mastocytosis
- (2013) J. Schwaab et al. BLOOD
- Primary Mast Cell Disorders in Children
- (2013) Ari J. Fried et al. CURRENT ALLERGY AND ASTHMA REPORTS
- Synergistic growth-inhibitory effects of ponatinib and midostaurin (PKC412) on neoplastic mast cells carrying KIT D816V
- (2013) K. V. Gleixner et al. HAEMATOLOGICA
- Gastrointestinal manifestations in mastocytosis: A study of 83 patients
- (2013) Harry Sokol et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The pan-Bcl-2 blocker obatoclax promotes the expression of Puma, Noxa, and Bim mRNA and induces apoptosis in neoplastic mast cells
- (2013) B. Peter et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Molecular mechanisms of glucocorticoid action in mast cells
- (2013) Emmanuel Oppong et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Systemic Mastocytosis With Associated Clonal Hematologic Nonmast Cell Lineage Disease: A Clinicopathologic Review
- (2012) Maggie M. Stoecker et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Interferon-α Treatment in Systemic Mastocytosis
- (2012) Ole Weis Bjerrum CURRENT DRUG TARGETS
- Mast cell leukemia: identification of a new c-Kit mutation, dup(501-502), and response to masitinib, a c-Kit tyrosine kinase inhibitor
- (2012) Sophie Georgin-Lavialle et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Serum IL-31 levels are increased in a subset of patients with mastocytosis and correlate with disease severity in adult patients
- (2012) Karin Hartmann et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Complete Response After Imatinib Mesylate Therapy in a Patient With Well-Differentiated Systemic Mastocytosis
- (2012) Iván Álvarez-Twose et al. JOURNAL OF CLINICAL ONCOLOGY
- The actual role of sodium cromoglycate in the treatment of asthma—a critical review
- (2012) Nikolaus C. Netzer et al. Sleep and Breathing
- Diagnosis, progression patterns and prognostication in mastocytosis
- (2012) Wolfgang R Sperr et al. Expert Review of Hematology
- Interferon Alpha and Pamidronate in Osteoporosis with Fracture Secondary to Mastocytosis
- (2011) Michel Laroche et al. AMERICAN JOURNAL OF MEDICINE
- mTORC1 and mTORC2 differentially regulate homeostasis of neoplastic and non-neoplastic human mast cells
- (2011) D. Smrz et al. BLOOD
- KIT-D816V-independent oncogenic signaling in neoplastic cells in systemic mastocytosis: role of Lyn and Btk activation and disruption by dasatinib and bosutinib
- (2011) K. V. Gleixner et al. BLOOD
- Systemic Mastocytosis
- (2011) Tracy I. George et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Definitions, Criteria and Global Classification of Mast Cell Disorders with Special Reference to Mast Cell Activation Syndromes: A Consensus Proposal
- (2011) Peter Valent et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- Aberrant expression of CD30 in aggressive systemic mastocytosis and mast cell leukemia: a differential diagnosis to consider in aggressive hematopoietic CD30-positive neoplasms
- (2011) Peter Valent et al. LEUKEMIA & LYMPHOMA
- Refractory Symptoms Successfully Treated with Leukotriene Inhibition in a Child with Systemic Mastocytosis
- (2011) PAUL J. TURNER et al. PEDIATRIC DERMATOLOGY
- Masitinib for the treatment of systemic and cutaneous mastocytosis with handicap: A phase 2a study
- (2010) Carle Paul et al. AMERICAN JOURNAL OF HEMATOLOGY
- Systemic mastocytosis and bone involvement in a cohort of 75 patients
- (2010) S. Barete et al. ANNALS OF THE RHEUMATIC DISEASES
- Phenotypic heterogeneity, novel diagnostic markers, and target expression profiles in normal and neoplastic human mast cells
- (2010) Peter Valent et al. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Pediatric mastocytosis-associated KIT extracellular domain mutations exhibit different functional and signaling properties compared with KIT-phosphotransferase domain mutations
- (2010) Y. Yang et al. BLOOD
- How I treat patients with advanced systemic mastocytosis
- (2010) P. Valent et al. BLOOD
- In vitro and in vivo growth-inhibitory effects of cladribine on neoplastic mast cells exhibiting the imatinib-resistant KIT mutation D816V
- (2010) Alexandra Böhm et al. EXPERIMENTAL HEMATOLOGY
- H1-receptor antagonists terfenadine and loratadine inhibit spontaneous growth of neoplastic mast cells
- (2010) Emir Hadzijusufovic et al. EXPERIMENTAL HEMATOLOGY
- Antimicrobial Peptides Human -Defensins and Cathelicidin LL-37 Induce the Secretion of a Pruritogenic Cytokine IL-31 by Human Mast Cells
- (2010) F. Niyonsaba et al. JOURNAL OF IMMUNOLOGY
- Aberrant expression of CD30 in neoplastic mast cells in high-grade mastocytosis
- (2010) Karl Sotlar et al. MODERN PATHOLOGY
- Pathogenesis, classification and treatment of mastocytosis: state of the art in 2010 and future perspectives
- (2010) Michel Arock et al. Expert Review of Hematology
- Anaesthesia in patients with mastocytosis
- (2009) F. M. Konrad et al. ACTA ANAESTHESIOLOGICA SCANDINAVICA
- Cytoreductive therapy in 108 adults with systemic mastocytosis: Outcome analysis and response prediction during treatment with interferon-alpha, hydroxyurea, imatinib mesylate or 2-chlorodeoxyadenosine
- (2009) Ken H. Lim et al. AMERICAN JOURNAL OF HEMATOLOGY
- Identification of proapoptotic Bim as a tumor suppressor in neoplastic mast cells: role of KIT D816V and effects of various targeted drugs
- (2009) K. J. Aichberger et al. BLOOD
- Phospho-STAT5 and phospho-Akt expression in chronic myeloproliferative neoplasms
- (2009) Lizz F. Grimwade et al. BRITISH JOURNAL OF HAEMATOLOGY
- Midostaurin (PKC412) inhibits immunoglobulin E-dependent activation and mediator release in human blood basophils and mast cells
- (2009) M.-T. Krauth et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Anaphylaxis: Recent advances in assessment and treatment
- (2009) F. Estelle R. Simons JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Pediatric Mastocytosis Is a Clonal Disease Associated with D816V and Other Activating c-KIT Mutations
- (2009) Christine Bodemer et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Masitinib is Safe and Effective for the Treatment of Canine Mast Cell Tumors
- (2009) K.A. Hahn et al. JOURNAL OF VETERINARY INTERNAL MEDICINE
- Masitinib (AB1010), a Potent and Selective Tyrosine Kinase Inhibitor Targeting KIT
- (2009) Patrice Dubreuil et al. PLoS One
- Mast cells and mastocytosis
- (2008) D. D. Metcalfe BLOOD
- Successful treatment of progressive cutaneous mastocytosis with imatinib in a 2-year-old boy carrying a somatic KIT mutation
- (2008) K. M. Hoffmann et al. BLOOD
- Oncogenic Kit controls neoplastic mast cell growth through a Stat5/PI3-kinase signaling cascade
- (2008) N. Harir et al. BLOOD
- Phase II, Open-Label Study Evaluating the Activity of Imatinib in Treating Life-Threatening Malignancies Known to Be Associated with Imatinib-Sensitive Tyrosine Kinases
- (2008) M. C. Heinrich et al. CLINICAL CANCER RESEARCH
- Phase II Study of Dasatinib in Philadelphia Chromosome-Negative Acute and Chronic Myeloid Diseases, Including Systemic Mastocytosis
- (2008) S. Verstovsek et al. CLINICAL CANCER RESEARCH
- Cutaneous Mastocytosis: A Review Focusing on the Pediatric Population
- (2008) Laura D. Briley et al. CLINICAL PEDIATRICS
- Dasatinib therapy for systemic mastocytosis: four cases
- (2008) Duncan Purtill et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Prevention of Mast Cell Activation Disorder-Associated Clinical Sequelae of Excessive Prostaglandin D2 Production
- (2008) Joseph H. Butterfield et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- Safety and effectiveness of immunotherapy in patients with indolent systemic mastocytosis presenting with Hymenoptera venom anaphylaxis
- (2008) David González de Olano et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Gastrointestinal manifestations of systemic mastocytosis
- (2008) Jason K Lee et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Mast cells: Versatile regulators of inflammation, tissue remodeling, host defense and homeostasis
- (2007) Stephen J. Galli et al. JOURNAL OF DERMATOLOGICAL SCIENCE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started